![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
TRVN Trevena
- 1.810
- 0.0000.00%
15min DelayClose Feb 14 16:00 ET
1.56MMarket Cap-0.04P/E (TTM)
1.930High1.630Low930Volume1.930Open1.810Pre Close1.67KTurnover0.11%Turnover RatioLossP/E (Static)863.79KShares17.50052wk High-0.07P/B1.55MFloat Cap1.13052wk Low--Dividend TTM855.59KShs Float8481.250Historical High--Div YieldTTM16.58%Amplitude1.130Historical Low1.799Avg Price1Lot Size
Trevena Stock Forum
Sign in to post a comment
30 Stocks below $2 to watch out for high risk high return.
Pharmaceutical: $Esperion Therapeutics (ESPR.US)$ $Seelos Therapeutics (SEEL.US)$ $Scilex Holding (SCLX.US)$ $Trevena (TRVN.US)$ $111 Inc (YI.US)$ $Cue Biopharma (CUE.US)$
Frac Sand: $Smart Sand (SND.US)$
Graphite Electrode: $GrafTech (EAF.US)$
Crypto Mining: $Bit Origin (BTOG.US)$
Artificial Intelligence: $Veritone (VERI.US)$
IOT Security: $Gorilla Technology (GRRR.US)$
Holographic: $WiMi Hologram Cloud (WIMI.US)$
Real Est...
Pharmaceutical: $Esperion Therapeutics (ESPR.US)$ $Seelos Therapeutics (SEEL.US)$ $Scilex Holding (SCLX.US)$ $Trevena (TRVN.US)$ $111 Inc (YI.US)$ $Cue Biopharma (CUE.US)$
Frac Sand: $Smart Sand (SND.US)$
Graphite Electrode: $GrafTech (EAF.US)$
Crypto Mining: $Bit Origin (BTOG.US)$
Artificial Intelligence: $Veritone (VERI.US)$
IOT Security: $Gorilla Technology (GRRR.US)$
Holographic: $WiMi Hologram Cloud (WIMI.US)$
Real Est...
12
2
5
Trevena Announces $2M Non-Dilutive Financing Tranche and Reduction in Outstanding Liabilities.
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company dedicated to developing and commercializing innovative medicines for patients with central nervous system (CNS) disorders, has recently announced a amendment to its March 2022 ex-US royalty-based financing agreement with R-Bridge Healthcare Fund, L.P. (R-Bridge). This development repr...
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company dedicated to developing and commercializing innovative medicines for patients with central nervous system (CNS) disorders, has recently announced a amendment to its March 2022 ex-US royalty-based financing agreement with R-Bridge Healthcare Fund, L.P. (R-Bridge). This development repr...
1
$Trevena (TRVN.US)$ Trevena Inc: Expects a $10 Mln Reduction in Liabilities Associated With Its Ex-US Royalty Financing
1
6
$Trevena (TRVN.US)$
Trevena Announces $2M Non-Dilutive Financing Tranche and Reduction in Outstanding Liabilities in Connection with Existing ex-US Royalty Financing
Trevena Announces $2M Non-Dilutive Financing Tranche and Reduction in Outstanding Liabilities in Connection with Existing ex-US Royalty Financing
1
$Trevena (TRVN.US)$ Trevena Announces $2M Non-Dilutive Financing Tranche and Reduction in Outstanding Liabilities in Connection With Existing Ex-US Royalty Financing
1
2
$Trevena (TRVN.US)$ daily volume remains consistently low, and price is relatively stable.
Waiting game….![]()
![]()
Waiting game….
No comment yet
Trending Stocks
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1
Popular on moomoo
Feb 13 17:34
China's asset revaluation sparks debate: What are mooers buying?
Tonyco : $bluebird bio (BLUE.US)$
$X4 Pharmaceuticals (XFOR.US)$
$Edible Garden (EDBL.US)$
HailTheApocalypse Tonyco : I would scratch out Blueturd.